A new pipeline drug, RBP-7000, developed by Indivior for the treatment of schizophrenia, has the potential to improve patient compliance, according to research performed by consulting firm GlobalData. more

Mar 24, 2017 12:18 PM News

It has been announced that Chemische Fabrik Budenheim site in Budenheim, Germany, has recently been awarded an EXCiPACT GMP/GDP certificate from SGS — one of EXCiPACT’s internationally recognised certification bodies. more

Mar 24, 2017 12:07 PM News

NICE has updated its guidance surrounding the treatment of post-menopausal women with a family history of breast cancer, stating that they should be offered anastrozole. more

Mar 24, 2017 11:52 AM News

Aprea Therapeutics, Karolinska Development’s portfolio company, has announced a collaboration with Memorial Sloan Kettering Cancer Center to study the effects of reactivation of tumour suppressor protein p53 by APR-246. more

Mar 24, 2017 11:32 AM News

After President Trump’s announcement of budget cuts to US governmental scientific agencies last week, the ISCT has stated that ramifications to science, clinical care and patients in the US and internationally will be severe and harmful. more

Mar 24, 2017 11:28 AM News

The US FDA has approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s currently being administered levodopa/carbidopa and experiencing ‘off’ periods. more

Mar 23, 2017 12:23 PM News

AMRI has been recognised for its excellence as a CMO and has been honoured as part of the Life Science Leader’s 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability. more

Mar 23, 2017 12:18 PM News

Ophthalmic Squeeze Dispenser

Courtesy of Allergan

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is now available for the first time for patients in the US prescription market using Allergan’s Restasis MultiDose 0.05%. more

Mar 23, 2017 11:57 AM News

Medical Expo
Tech New
Home New
Built with Metro Publisher™